Welcome to the PHENPath.com Blog
The Jackson, Mississippi Prostate Cancer Disparity Rally mobilized leaders to record prostate cancer awareness messages.
As part of the Jackson, MS Disparity Rally, Dr. Timothy Quinn, the Medical Director of Quinn Healthcare, explains the importance of early prostate cancer detection to save lives. Dr. Quinn advises men to visit PHENPath.com for information on the latest prostate cancer...
PHENPath.com – Empowering Patients
PHENPath.com - Empowering Patients Drawing on his experience as a prostate cancer survivor, PHEN President Thomas A. Farrington explains that newly diagnosed prostate cancer patients often lack knowledge about the right treatment pathways for their needs. To solve...
PHEN Supports Talapro-3 Clinical Trial
PHEN's Clinical Trials Rally's approach of educating Black prostate cancer patients about clinical trials, as well as strategic partnerships with pharmaceutical companies to amplify this message, is contributing to greater diversity among clinical trial participants....
The FDA approves a new prostate cancer combination treatment based upon a successful clinical trial
The U.S. Food and Drug Administration (FDA) recently approved TALZENNA (talazoparib) in combination with XTANDI (enzalutamide) for the treatment of adult patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer...
If you are experiencing PSA recurrence after surgery, PHENPath.com provides information about available treatment options as set forth by NCCN Guidelines®
This information is provided for educational purposes only to support patients in understanding and discussing appropriate treatment options with their doctors. [button...
PHENPath.com supports patients in making informed and shared-decisions with their doctors about their Prostate Cancer treatment – Resources that will help you along your journey.
PHEN, The Prostate Health Education Network, Inc. is a leading patient education and advocacy organization with programs and initiatives nationwide. PHENPath.com was developed to help patients understand their treatment pathways and treatment options. We invite you to...
PHENPath.com is highlighted by Amgen.com in their recently published article, “Building Towards Patient-Centered Clinical Pathways”
PHEN is a partner organization of the Amgen Clinical Pathways initiative, PHENPath.com helps empower prostate cancer patients through its first digital treatment pathway tool of its kind. We encourage you to read the article by clicking the button link below [button...
PHENPath.com provides helpful information about your Initial Prostate Cancer Diagnosis. We invite you to learn more if you are a patient diagnosed with prostate cancer prior to any treatment.
PHENPath.com provides information for patients who want to better understand their initial Prostate cancer diagnosis. ...
Webinar: Understanding where you are on your prostate cancer journey! Presented by PHENPath.com and the Prostate Health Education Network
Webinar: A Presentation and Patient Roundtable Discussion The following webinar was presented March 31, 2021. This webinar focused on real-life experiences and helped to demonstrate how to use PHENPath.com to navigate your prostate cancer journey.Understanding...
Do You Know Where You Are On Your Prostate Cancer Journey?
Introducing PHEN's "Patient Treatments Education and Empowerment Webinar Series: Understanding Treatment Pathways" To educate patients about their treatment pathways and options, and to empower them and their families to make informed shared decisions with their...
Prostate cancer testing may include blood, imaging, and tissue tests to check for signs of disease and are also used to plan treatments and review how treatments are working.
PHENPath helps patients to understand their treatment pathways and treatment options. To learn more about the types of testing you may undergo throughout your prostate cancer journey, click the button below. [button...
What is the Prostate? How big is the Prostate? What is Prostate Cancer? Learn the answers to these and other questions that will help you better understand your prostate cancer diagnosis.
PHENPath.com provides insight to common questions about the prostate and your cancer diagnosis.
Recent Posts
The Jackson, Mississippi Prostate Cancer Disparity Rally mobilized leaders to record prostate cancer awareness messages.
PHENPath.com – Empowering Patients- PHEN Supports Talapro-3 Clinical Trial
- The FDA approves a new prostate cancer combination treatment based upon a successful clinical trial
- If you are experiencing PSA recurrence after surgery, PHENPath.com provides information about available treatment options as set forth by NCCN Guidelines®
